| 000 | 00931 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250511150945.0 | ||
| 264 | 0 | _c19800119 | |
| 008 | 198001s 0 0 eng d | ||
| 022 | _a0141-2760 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSobel, A T | |
| 245 | 0 | 0 |
_aThe second component of complement (C2) as an index of hereditary angioneurotic edema. _h[electronic resource] |
| 260 |
_bJournal of clinical & laboratory immunology _cNov 1978 |
||
| 300 |
_a179-81 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAngioedema _xdiagnosis |
| 650 | 0 | 4 | _aComplement C1 Inactivator Proteins |
| 650 | 0 | 4 | _aComplement C2 |
| 650 | 0 | 4 | _aComplement C4 |
| 650 | 0 | 4 |
_aDanazol _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 700 | 1 | _aMoisy, M | |
| 700 | 1 | _aBelghiti, D | |
| 700 | 1 | _aGabay, Y | |
| 700 | 1 | _aLagrue, G | |
| 773 | 0 |
_tJournal of clinical & laboratory immunology _gvol. 1 _gno. 3 _gp. 179-81 |
|
| 999 |
_c776806 _d776806 |
||